VET3-TGI

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NameVET3-TGI
Drug Alias NameVET3 TGI
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsSolid tumoursKidney NeoplasmsUterine Cervical Neoplasms +[13
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKaliVir Immunotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursKidney NeoplasmsUterine Cervical Neoplasms +[13
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A